Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
92 studies found for:    Open Studies | "Endometrial Neoplasms"
Show Display Options
Rank Status Study
21 Unknown  Retrospective Study to Evaluate the Feasibility of Ovarian Preservation in Patients With Endometrial Carcinoma
Condition: Endometrial Cancer
Intervention: Procedure: surgery
22 Recruiting Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: Dasatinib
23 Recruiting Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery
Conditions: Stage I Endometrial Carcinoma;   Stage II Endometrial Carcinoma;   Stage III Endometrial Carcinoma;   Stage IV Endometrial Carcinoma
Interventions: Procedure: lymph node mapping;   Procedure: sentinel lymph node biopsy;   Drug: isosulfan blue;   Drug: indocyanine green solution;   Procedure: therapeutic conventional surgery;   Procedure: lymphadenectomy
24 Not yet recruiting A Parp Inhibitor (BMN 673) for Inoperable Advanced eNDometrial cAncer
Condition: Endometrial Cancer
Intervention: Drug: BMN 673
25 Unknown  Study of Genes and the Environment in Patients With Endometrial Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
Condition: Endometrial Cancer
Interventions: Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: questionnaire administration
26 Recruiting Follow-up of Endometrial Cancer Patients
Condition: Endometrial Cancer
Intervention: Other: Instruction in self-referral
27 Recruiting A Pilot Study to Determine the Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion
Condition: Endometrial Cancer
Intervention: Drug: Fluorescein
28 Unknown  Radiation Therapy Sandwiched Between Paclitaxel and Carboplatin in Patients With High-risk Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Radiation: Pelvic and Para-Aortic Radiation 6MV Photon Beam Energy;   Radiation: High Dose Radiation
29 Recruiting Effect of Curcumin Addition to Standard Treatment on Tumour-induced Inflammation in Endometrial Carcinoma
Condition: Endometrial Carcinoma
Intervention: Dietary Supplement: Curcuphyt
30 Recruiting Lymphedema in Endometrial Cancer
Conditions: Lower Extremity Lymphedema;   Endometrial Cancer
Intervention:
31 Recruiting Probe-based and Needle-based Confocal Laser Endomicroscopy During Gynaecological Procedures.
Conditions: Cervix Cancer;   Endometrium Cancer;   Ovarian Cancer;   Carcinoma in Situ of Fallopian Tube
Intervention: Device: Confocal Laser Endomicroscopy (CLE)
32 Unknown  Prognostic Biomarkers in Patients With Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Genetic: DNA analysis;   Genetic: mutation analysis;   Other: laboratory biomarker analysis
33 Recruiting Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CA
Condition: Recurrent or Persistent Endometrial Carcinoma
Intervention: Drug: Sodium cridanimod
34 Recruiting Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: carboplatin and paclitaxel;   Other: observation
35 Recruiting Trial Between Two Follow up Regimens With Different Test Intensity in Endometrial Cancer Treated Patients
Condition: Endometrial Cancer
Interventions: Procedure: Intensive/Low-Risk Treatment (IA G1; IA G2);   Procedure: Intensive/High-Risk Treatment (≥ IA G3);   Procedure: Minimalist/Low-Risk Treatment (IA G1; IA G2);   Procedure: Minimalist/High-Risk Treatment (≥ IA G3)
36 Recruiting Linking Obesity and Estrogen-responsive Genes in Endometrial Cancer
Condition: Endometrial Cancer
Intervention:
37 Not yet recruiting Endometrial Cancer Biomarker Changes Following Exposure to Metformin
Condition: Endometrial Cancer
Intervention: Drug: Metformin
38 Not yet recruiting Biomarkers in Tumor Tissue Samples From Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
Conditions: Recurrent Endometrial Carcinoma;   Stage III Endometrial Carcinoma;   Stage IV Endometrial Carcinoma
Intervention: Other: laboratory biomarker analysis
39 Unknown  The Assessment of Preoperative Psychological Intervention on Stress in Women With Gynecological Malignancies
Conditions: Cancer of Cervix;   Ovarian Cancer;   Cancer of Endometrium
Interventions: Behavioral: Cognitive intervention;   Other: Control group;   Other: psycho-physiological intervention
40 Recruiting Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer
Conditions: Recurrent Endometrial Carcinoma;   Recurrent Fallopian Tube Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Primary Peritoneal Cavity Cancer;   Stage IIIA Endometrial Carcinoma;   Stage IIIA Fallopian Tube Cancer;   Stage IIIA Ovarian Epithelial Cancer;   Stage IIIA Primary Peritoneal Cavity Cancer;   Stage IIIB Endometrial Carcinoma;   Stage IIIB Fallopian Tube Cancer;   Stage IIIB Ovarian Epithelial Cancer;   Stage IIIB Primary Peritoneal Cavity Cancer;   Stage IIIC Endometrial Carcinoma;   Stage IIIC Fallopian Tube Cancer;   Stage IIIC Ovarian Epithelial Cancer;   Stage IIIC Primary Peritoneal Cavity Cancer;   Stage IV Fallopian Tube Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Primary Peritoneal Cavity Cancer;   Stage IVA Endometrial Carcinoma;   Stage IVB Endometrial Carcinoma
Interventions: Procedure: therapeutic conventional surgery;   Drug: cisplatin;   Drug: carboplatin;   Drug: paclitaxel;   Drug: pegylated liposomal doxorubicin hydrochloride;   Drug: gemcitabine hydrochloride;   Procedure: quality-of-life assessment;   Other: laboratory biomarker analysis

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years